← Eichor
Condition: Hiv Aids Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hiv Aids

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06624839The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901Structured Peer-delivered ART and Reentry Community Strategy
NA · 1 location(s) · Johns Hopkins University · NCT06027671We-INtervention Among Chinese HIV-serodiscordant Male Couples
NA · 4 location(s) · City University of Hong Kong · NCT06639932Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based Approach
NA · 1 location(s) · RTI International · NCT07574619Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
NA · 2 location(s) · Washington University School of Medicine · NCT07002866Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation
NA · 6 location(s) · Northwestern University · NCT06880224The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
Phase N/A · 1 location(s) · University of California, San Francisco · NCT01202305Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Phase 3 · 5 location(s) · Federal University of Health Science of Porto Alegre · NCT05814432Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Phase 4 · 3 location(s) · University of Witwatersrand, South Africa · NCT06485154Improving Engagement in HIV and Cancer Care in Zimbabwe
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT06934369Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT07388394A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
NA · 1 location(s) · Florida International University · NCT06586619The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07284082Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and W
Phase 1 · 3 location(s) · International AIDS Vaccine Initiative · NCT06617091Accelerated ART Initiation for PWHIV Who Are Out of Care
Phase 4 · 4 location(s) · University of Missouri-Columbia · NCT06374758Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
NA · 1 location(s) · University of California, San Francisco · NCT07125235Strategies to AchieVe Viral Suppression for Youth With HIV
NA · 1 location(s) · Johns Hopkins University · NCT06886971Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
NA · 1 location(s) · University of Washington · NCT06745050Enhancing the Organizational Social Context to Improve Viral Suppression and Retention in HIV Care
NA · 1 location(s) · University of Pennsylvania · NCT06462807Text Education About Cardiovascular Health and HIV (TEACH-HIV)
NA · 2 location(s) · University of California, San Francisco · NCT05642858DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)
Phase 2 · 4 location(s) · University Hospital, Caen · NCT06034938Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
Phase 1 · 11 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07390955A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.